Endocrinopathies in Childhood Cancer Survivors

Endocrinologist

Volumn 13, Issue 6, 2003, Pages 488-495

  Rose, Susan R ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Division of Endocrinology   (United States)

Author keywords

Adrenal insufficiency; Delayed puberty; Diabetes insipidus; Growth hormone deficiency; Hypothyroidism; Late effects; Oncology; Osteoporosis; Precocious puberty

Indexed keywords

CALCIUM; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; VITAMIN D;

ACCURACY; ANOREXIA; AVASCULAR NECROSIS; BODY HEIGHT; BODY WEIGHT; BONE DISEASE; CALCIUM INTAKE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CATCH UP GROWTH; CHILDHOOD CANCER; CONSTIPATION; CORTICOTROPIN DEFICIENCY; DELAYED PUBERTY; DIABETES INSIPIDUS; DRY SKIN; ENDOCRINE DISEASE; FAILURE TO THRIVE; FATIGUE; FRACTURE; FREE THYROXINE INDEX; GONADAL DISEASE; GONADOTROPIN DEFICIENCY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH INHIBITION; HAIR DISEASE; HEALTH SURVEY; HORMONE DEFICIENCY; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS DISEASE; HYPOTHYROIDISM; INFERTILITY; IRRADIATION; LIMB; MEDULLOBLASTOMA; OBESITY; OSTEOPENIA; PRECOCIOUS PUBERTY; PUBERTY; REVIEW; SCOLIOSIS; SKULL IRRADIATION; SLEEP DISORDER; SPINAL CORD; SYMPTOM; THYROID DISEASE; TUMOR LOCALIZATION; VITAMIN INTAKE; WEIGHT REDUCTION; WHOLE BODY RADIATION;

EID: 0344530521     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000098611.49230.10     Document Type: Review

References (46)

1. Miller BA, Ries LA, Hankey BF, et al. SEER Cancer Statistics Review: 1973-1990. NIH Publication no. 93-2789. Bethesda, MD: National Cancer Institute; 1993.
2. Blatt J, Copeland DR, Bleyer WA. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, 2nd ed. Philadelphia: JB Lippincott Co; 1993.
3. Yeung SC, Chiu AC, Vassilopoulou-Sellin R, et al. The endocrine effects of nonhormonal antineoplastic therapy. Endocr Rev. 1998;19:144-172.
4. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2002;87:3136-3141.
5. UpToDate [www.uptodate.com]. Available from UpToDate, Inc, 34 Washington St, Wellesley, MA 02481-1903.
6. Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am. 1997;44:489-503.
7. Littley MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Metab. 1990;4:147-175.
8. Rose SR, Lustig RH, Burstein S, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab. 1999;84:4472-4479.
9. Shalet SM, Beardwell CG, Pearson D, et al. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf). 1976;5:287-290.
10. Rose SR, Schreiber RE, Kearney NS, et al. Hormone deficiencies after chemotherapy alone. Pediatr Res. 2001;49:87A:P1, Abstract 519.
11. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85:3990-3993.
12. Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children, from The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr. 2003 (in press).
13. Swerdlow AJ, Reddingius RE, Higgins CD, et al. Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab. 2000;85:4444-4449.
14. Leung W, Rose SR, Zhou Y, et al. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2002;20:2959-2664.
15. Khoo VS, Liew KH, Crennan EC, et al. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients. Australas Radiol. 1998;42:52-57.
16. Rose SR. Disorders of thyrotropin synthesis, secretion, and function. Curr Opin Pediatr. 2000;12:375-381.
17. Persani L. Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity. Thyroid. 1998;8:941-946.
18. Merchant TE, Williams T, Smith JM, et al. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys. 2002;54:45-50.
19. Ferretti E, Persani L, Jaffrain-Rea ML, et al. Evaluation of the adequacy of levothyroxine replacement in patients with central hypothyroidism. J Clin Endocrinol Metab. 1999;84:924-929.
20. Yanovski JA. Anesthesia in patients with adrenal disorders. Anesthesia Today. 1997;8:5-9.
21. Shankar RR, Jakacki RI, Haider A, et al. Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors. J Clin Endocrinol Metab. 1997;82:1995-1998.
22. Oberfield SE, Nirenberg A, Allen JC, et al. Hypothalamic-pituitary-adrenal function following cranial irradiation. Horm Res. 1997;47:9-16.
23. Rose SR, Danish PK, Schreiber RE, et al. ACTH deficiency in childhood cancer survivors. Pediatr Res. 2002;51:116A, Abstract 674.
24. Rose SR, Lustig RH, Burstein S, et al. Diagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res. 1999;52:71-77.
25. Linder BL, Esteban NV, Yergey AL, et al. Cortisol production rate in childhood and adolescence. J Pediatr. 1990;117:892-896.
26. Pitukcheewanont P, Burstein S, Rose SR, et al. Management of postoperative and post-traumatic diabetes insipidus in children. Endocrinologist. 1996;6:301-306.
27. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505-512.
28. Mills JL, Fears TR, Robison LL, et al. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr. 1997;131:598-602.
29. Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumors. Arch Dis Child. 1995;73:141-146.
30. Bath LE, Hamish W, Wallace B, et al. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109:107-114.
31. Mattano LA Jr, Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000;18:3262-3272.
32. Socie G, Selimi F, Sedel L, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol. 1994;86:624-628.
33. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia. 2001;15:891-897.
34. Castro FP Jr, Barrack RL. Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis. Am J Orthop. 2000;29:187-194.
35. Seller K, Raab P, Wild A, et al. Risk-benefit analysis of prophylactic pinning in slipped capital femoral epiphysis. J Pediatr Orthop. 2001;10:192-196.
36. Mithal NP, Almond MK, Evans K, et al. Reduced bone mineral density in long-term survivors of medulloblastoma. Br J Radiol. 1993;66:814-816.
37. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001;15:728-734.
38. Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of low femoral bone density in older U. S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768.
39. Haddy TB, Mosher RB, Reaman GH. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist. 2001;6:278-285.
40. Mora S, Pitukcheewanont P, Kaufman FR, et al. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res. 1999;14:1664-1671.
41. Canalis E. Novel treatments for osteoporosis. J Clin Invest. 2000;106:177-179.
42. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611-616.
43. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity in children due to cranial insult: altered insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999;135:162-168.
44. Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med. 2002;156:887-892.
45. Oberfield SE, Sklar CA. Endocrine sequelae in survivors of childhood cancer. Adolesc Med. 2002;13:161-169.
46. Meacham LR, Ghim TT, Crocker IR, et al. Systematic approach for detection of endocrine disorders in children treated for brain tumors. Med Pediatr Oncol. 1997;29:86-91.